MindMed stock just saw its potential soar now that it's listed on the Nasdaq. MindMed (NASDAQ: MNMD) is a Toronto-based company using psychedelic medicine to treat a list of health issues. The company started trading on the NASDAQ Tuesday, April 27. But is MindMed stock a buy? The post Why MindMed Stock's Jump to the Nasdaq Is a Game Changer appeared first on Money Morning - We Make Investing Profitable .